Holen Sie sich die Stockscreener-App
3.50
0.57%
-0.02
Handel nachbörslich:
3.50
Schlusskurs vom Vortag:
$3.52
Offen:
$3.57
24-Stunden-Volumen:
208.21K
Relative Volume:
0.40
Marktkapitalisierung:
$1.09B
Einnahmen:
$563.46M
Nettoeinkommen (Verlust:
$27.92M
KGV:
36.31
EPS:
0.0964
Netto-Cashflow:
$-146.33M
1W Leistung:
-0.57%
1M Leistung:
-4.11%
6M Leistung:
-28.28%
1J Leistung:
-57.98%
1-Tages-Spanne:
$3.465
$3.61
1-Wochen-Bereich:
$3.30
$3.61
52-Wochen-Spanne:
$3.03
$11.85
Alvotech Stock (ALVO) Company Profile
Compare ALVO vs TAK, ZTS, TEVA, HLN, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ALVO
Alvotech
|
3.50 | 1.10B | 563.46M | 27.92M | -146.33M | 0.0964 |
TAK
Takeda Pharmaceutical Co Adr
|
16.55 | 52.32B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
112.54 | 47.38B | 9.47B | 2.67B | 2.28B | 6.0218 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
35.86 | 41.16B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.17 | 41.02B | 14.54B | 2.22B | 2.58B | 0.4871 |
UTHR
United Therapeutics Corp
|
572.20 | 24.67B | 3.18B | 1.33B | 1.04B | 27.90 |
Alvotech Stock (ALVO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-09 | Eingeleitet | Barclays | Underweight |
| 2025-11-04 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2025-10-14 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2025-09-23 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2025-02-14 | Eingeleitet | UBS | Buy |
| 2024-01-29 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2023-10-20 | Hochstufung | Citigroup | Sell → Neutral |
| 2023-09-21 | Eingeleitet | Barclays | Equal Weight |
| 2022-09-07 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-09-06 | Herabstufung | Citigroup | Buy → Sell |
| 2022-07-26 | Eingeleitet | Citigroup | Buy |
Alle ansehen
Alvotech Aktie (ALVO) Neueste Nachrichten
Alvotech SA expected to post earnings of 2 cents a shareEarnings Preview - TradingView
Alvotech Announces General Counsel Transition After Six-Year Tenure - TipRanks
[6-K] Alvotech Current Report (Foreign Issuer) | ALVO SEC FilingForm 6-K - Stock Titan
Will Alvotech's (ALVO) Legal Transition and Executive Move to Reykjavik Quietly Reframe Its Governance Story? - simplywall.st
Earnings Preview: Alvotech to Report Financial Results Post-market on May 06 - 富途牛牛
Deutsche Bank Downgrades Alvotech (ALVO) - MSN
Alvotech Announces a Change in its Executive Team - The Manila Times
Alvotech : General MeetingALVOTECH - marketscreener.com
Alvotech (ALVO) to Release Quarterly Earnings on Wednesday - MarketBeat
Alvotech (NASDAQ:ALVO) Trading 7.1% HigherStill a Buy? - MarketBeat
Why is ALVO stock rising pre-market today? - MSN
Alvotech’s AVT03 approved by European Commission as biosimilar to Prolia and Xgeva - MSN
Dr Reddy's, Alvotech join hands to co-develop, manufacture & commercialise biosimilar of Merck's blockbuster drug Keytruda - MSN
Alvotech CCO Anil Okay steps down to become Adalvo CEO - MSN
Alvotech stock slides as FDA issues CRL for AVT05, company cuts EBITDA outlook - msn.com
Alvotech (ALVO) Valuation Gap Under Review After Mixed Share Performance And Biosimilar Pipeline Progress - Yahoo Finance
Alvotech to Report Financial Results for the First Quarter of 2026 - marketscreener.com
Alvotech to Announce First Quarter 2026 Financial Results and Host Webcast on May 7, 2026 - Quiver Quantitative
Quant snapshot: Micron, Babcock & Wilcox lead strong buys as Fold Holdings, Alvotech lag - MSN
Alvotech : Inside Information / Ad Hoc InformationALVOTECH - marketscreener.com
Alvotech (NASDAQ:ALVO) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
Here’s What the Street Thinks About Alvotech (ALVO) - Insider Monkey
Morgan Stanley Upgrades Alvotech (ALVO) - MSN
Wall Street Zen Upgrades Alvotech (NASDAQ:ALVO) to Hold - MarketBeat
Alvotech (NASDAQ:ALVO) Sees Significant Increase in Short Interest - MarketBeat
Alvotech stock (LU2557688560): Why does its biosimilar pipeline now matter more for U.S. investors? - AD HOC NEWS
Cash per share of Alvotech – DUS:Z45 - TradingView — Track All Markets
Alvotech Looks To Make Good On Two-Year Bet - Citeline News & Insights
ALVO SEC FilingsAlvotech 10-K, 10-Q, 8-K Forms - Stock Titan
ALVO Technical Analysis & Stock Price Forecast - Intellectia AI
Alvotech: Improving Fundamentals Signal Potential Bottom For This Biosimilar Player (ALVO) - Seeking Alpha
Retail Trends: Whats the outlook for Alvotech Equity Warrants sector2026 Snapshot & Safe Entry Trade Reports - baoquankhu1.vn
Alvotech’s Price Rises But Technical Signals Turn Bearish - Bitget
Performance Recap: Is Alvotech a top pick in the sector2026 Trade Ideas & Long-Term Growth Plans - baoquankhu1.vn
Why Is Alvotech (ALVOW) Stock Down Today? - Meyka
Alvotech stock: Biosimilar innovator with global growth potential - AD HOC NEWS
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Alvotech (NASDAQ:ALVO) Stock Price Down 9.5%Here's What Happened - MarketBeat
Alvotech Plummets 9.5% Amid Market Volatility and Sector Uncertainty - Bitget
Published on: 2026-04-07 05:57:03 - baoquankhu1.vn
Alvotech (NASDAQ:ALVO) Trading Up 7.2%Here's What Happened - MarketBeat
ETFs Investing in Alvotech Stocks - TradingView
Institution Moves: Is Alvotech stock overvalued or fairly pricedMarket Movers & Weekly High Return Forecasts - baoquankhu1.vn
Alvotech (NASDAQ:ALVO) Stock Rating Lowered by Wall Street Zen - MarketBeat
Finanzdaten der Alvotech-Aktie (ALVO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.67%
2.13%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):